| Authors: |
Slominski AT; Department of Dermatology, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama, USA; Cancer Chemoprevention Program, Comprehensive Cancer Center, The University of Alabama at Birmingham, Birmingham, Alabama, USA; Pathology and Laboratory Medicine Service, VA Medical Center, Birmingham, Alabama, USA. Electronic address: aslominski@uabmc.edu., Kim TK; Department of Dermatology, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama, USA., Janjetovic Z; Department of Dermatology, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama, USA., Slominski RM; Department of Medicine-Immunology/Rheumatology, The University of Alabama at Birmingham, Birmingham, Alabama, USA; Informatics Institute, The University of Alabama at Birmingham, Birmingham, Alabama, USA., Ganguli-Indra G; Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, Oregon, USA; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA., Athar M; Department of Dermatology, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama, USA; Pathology and Laboratory Medicine Service, VA Medical Center, Birmingham, Alabama, USA., Indra AK; Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, Oregon, USA; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA; Department of Dermatology, Oregon Health & Science University, Portland, Oregon, USA., Reiter RJ; Department of Cell Systems and Anatomy, Long School of Medicine, UT Health San Antonio, San Antonio, Texas, USA., Kleszczyński K; Department of Dermatology, University of Münster, Münster, Germany. Electronic address: konrad.kleszczynski@ukmuenster.de. |
